6,000 patients could benefit from €30 million for new medicines announced in Budget 2026 Minister’s commitment to adhering to the legislative timelines for new medicines decisions […]
IPHA welcomes the confirmation today (Tuesday 29th September) from the Minister for Health, Jennifer Carroll MacNeill TD, that the State will enter into formal talks on […]
Thursday 21st August 2025 IPHA notes the joint statement by the US and EU on tariffs today (Thursday), particularly the aspects dealing with pharmaceuticals. Some mitigation […]
Ireland continues to rank among the bottom of Western European countries when it comes to availability of newly licensed cancer treatments, according to a new report by data analysts IQVIA for EFPIA, the European pharmaceutical body.
The objective of Directive 91/271/EEC is to protect the environment from being adversely affected byinsufficiently treated urban wastewater discharges.
Today, (Wednesday 26th February) the Irish Pharmaceutical Healthcare Association (IPHA) publishes a position paper on the 2025 Programme for Government Commitments which makes the case for Faster and Fairer Access to Medicines.
Let’s give every patient in Ireland the chance to create new memories. Pfizer, Novo Nordisk, Roche and AbbVie feature in IPHA’s campaign which highlights how, […]
36 new IPHA medicines planned for 2025 has the potential to benefit up to 3,700 patients and funding will now ensure access to these advances in medicines […]
Central to IPHA’s General Election manifesto is an ask for the next Government to commit to a continuous and faster flow of new life-enhancing medicines, and vaccines, for patients in Ireland. The manifesto outlines innovative proposals on how this can be achieved.